Advanced search
Publication Cover
Bioanalysis Volume 11, 2019 - Issue 8
Submit an article Journal homepage
267
Views
0
CrossRef citations to date
0
Altmetric
Methodology

Development and Validation of Indirect and Generic Immunoassays to Quantify Free and Total Evolocumab in Rat Serum

Wenyan Wang1 Key Laboratory of Molecular Pharmacology & Drug Evaluation,School of Pharmacy, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System & Biotech Drugs in Universities of Shandong, Yantai University, Yantai264005, PR ChinaCorrespondence[email protected]
,
Lina Dong1 Key Laboratory of Molecular Pharmacology & Drug Evaluation,School of Pharmacy, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System & Biotech Drugs in Universities of Shandong, Yantai University, Yantai264005, PR China
,
Heyuan Sun1 Key Laboratory of Molecular Pharmacology & Drug Evaluation,School of Pharmacy, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System & Biotech Drugs in Universities of Shandong, Yantai University, Yantai264005, PR China
,
Limeng Zhu1 Key Laboratory of Molecular Pharmacology & Drug Evaluation,School of Pharmacy, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System & Biotech Drugs in Universities of Shandong, Yantai University, Yantai264005, PR China
&
Wanhui Liu1 Key Laboratory of Molecular Pharmacology & Drug Evaluation,School of Pharmacy, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System & Biotech Drugs in Universities of Shandong, Yantai University, Yantai264005, PR China
Pages 679-687 | Received 02 Jan 2019, Accepted 13 Mar 2019, Published online: 18 Apr 2019

References

  • Sjouke B , KustersDM, KasteleinJJ, HovinghGK. Familial hypercholesterolemia: present and future management. Curr. Cardiol. Rep.13(6), 527–536 (2011).
  • Melendez QM , KrishnajiST, WootenCJ, LopezD. Hypercholesterolemia: the role of PCSK9. Arch. Biochem. Biophys.625, 39–53 (2017).
  • Lambert G , SjoukeB, ChoqueB, KasteleinJJ, HovinghGK. The PCSK9 decade. J. Lipid Res.53, 2515–2524 (2012).
  • Ogura M . PCSK9 inhibition in the management of familial hypercholesterolemia. J. Cardiol.71(1), 1–7 (2018).
  • Repatha. Full prescribing information, Repatha (evolocumab). Reference ID 3812424[J]. (2015) https://www.ema.europa.eu/documents/product-information/repatha-epar-product-information_en.pdf
  • Robinson JG , FarnierM, KrempfMet al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N. Engl. J. Med.372, 1489–1499 (2015).
  • Sabatine MS , GiuglianoRP, WiviottSDet al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N. Engl. J. Med.372(16), 1500–1509 (2015).
  • Fischer SK . Factors that impact pharmacokinetic measurements of antibody therapeutics: what is your PK assay telling you?Bioanalysis9, 1531–1533 (2017).
  • Kuang B , KingL, WangHF. Therapeutic monoclonal antibody concentration monitoring: free or total?Bioanalysis2(6), 1125–1140 (2010).
  • Chilewski SD , FollmerT, AnsbroFet al. Validation of preclinical pharmacokinetic and immunogenicity assays for an anti-PCSK9 antibody. J. Immunoassay Immunochem.32(4), 296–317 (2011).
  • Zhang Q , SpellmanDS, SongYet al. Generic automated method for liquid chromatography-multiple reaction monitoring mass spectrometry based monoclonal antibody quantitation for preclinical pharmacokinetic studies. Anal. Chem.86(17), 8776–8784 (2014).
  • Peng K , XuK, LiuLet al. Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study. MAbs6(6), 1500–1508 (2014).
  • Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Rockville, MD, USA (2018). https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm070107.pdf
  • Jefferis R . Antibody therapeutics: isotype and glycoform selection. Expert Opin. Biol. Ther.7(9), 1401–1413 (2007).
  • Markham A . Atezolizumab: first global approval. Drugs76(12), 1227–1232 (2016).
  • Lux A , NimmerjahnF. No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer. Cancer Cell27(1), 10–11 (2015).
  • Puszkiel A , NoéG, Boudou-RouquettePet al. Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients. J. Pharm. Biomed. Anal.139, 30–36 (2017).
  • Passot C , DesvignesC, TernantDet al. Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum. Bioanalysis9, 1227–1235 (2017).
  • Hall CM , PearsonJT, PatelV, WienkersLC, GreeneRJ. An extended range generic immunoassay for total human therapeutic antibodies in preclinical pharmacokinetic studies. J. Immunol. Met.393(1–2), 70–73 (2013).
  • Henne KR , AsonB, HowardMet al. Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement. J. Pharmacol. Exp. Ther.353(1), 119–131 (2015).
  • Ni YG , DiMarco S, CondraJHet al. A PCSK9-binding antibody that structurally mimics the EGF (A) domain of LDL-receptor reduces LDL cholesterol in vivo. J. Lipid Res.52(1), 78–86 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.